Abstract

Multiple Myeloma (MM) is the 2nd most frequently diagnosed hematologic malignancy and accounts for 10-15% of all blood cancers and 1–1.8% of all cancers. Approximately 1% plasma cell myelomas are non-secretory (NSMM) and 15% of latter are non-producers (NSNPMM) where no cytoplasmic immunoglobulin (lg) synthesis is detected

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call